Printer Friendly
The Free Library
14,680,804 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CMIC, Celtic Pharma Form Strategic Alliance in Drug Development in Asia.


Tokyo, Japan, Sept 8, 2005 - (JCNN JCNN Japan Corporate News Network ) - CMIC CMIC CPU Management Interface Controller
CMIC Caucasus Media Investigations Center (Baku, Azerbaijan)
CMIC Combined Military Interrogation Center (Vietnam)
CMIC Configuration Management Information Center
, a Japanese CRO (contract research organization) company, announced on September 6 that it has agreed with Celtic Pharma Management to form a strategic alliance in clinical development of biotech and pharmaceutical products in Asia including Japan.

The partnership will enable Celtic Pharma to gain a foodhold in Asia and facilitate clinical studies of drug candidates in late-stage development.

Further, the two companies aim to accelerate the introduction of innovative and promising products to the Asian market. Celtic Pharma Management, which is based in Bermuda, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 and London, is a global private investment firm specialized in the biotech and pharmaceutical industry.

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Sep 10, 2005
Words:124
Previous Article:Sumitomo Chemical to Increase Anti-Malaria Mosquito Net Production in Tanzania.
Next Article:Toyota to Increase Production Capacity in France.



Related Articles
ESP Pharma Announces Strategic Marketing Alliance with European Based OTL Pharma; ESP Pharma Achieves Key Milestone in Establishing a Global...
ESP Pharma Significantly Expands Its Global Marketing Reach Through a Strategic Alliance with Korean-Based CJ Corporation, Pharmaceutical Division.
INYX MANUFACTURES ANTI-INFLAMMATORY FOAM FOR COLITIS.
Life Science Insights Ranks Leading CROs: Quality, Flexibility and Customer Focus Identified As Key Capabilities.
MDS Pharma Services Expands Clinical Research Capabilities in Asia-Pacific; New locations in Australia and Malaysia add to the company's global reach.
Nutra Pharma Penetrates the China Market.
Private equity firm leases its first Manhattan office.
CMIC to Establish New Subsidiary in Brazil, New Office in Shanghai.
Intec Pharma and Impax Laboratories to Collaborate on CNS Drug Using Accordion Pill(TM) Gastric Retention Technology.
Accium BioSciences and CMIC Announce Strategic Alliance to Provide Exploratory IND and Low-Radiation PK/ADME Services to the Japanese Pharmaceutical...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles